Insider Ledger
EWTX insider buying and SEC filings, explained
Edgewise Therapeutics, Inc. · CIK 1710072
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$199K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$15.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 13, 2026 | Planned (10b5-1) | Joanne M. Donovan (CMO) sold 2,919 shares at $43.41 ($127K), marked as a 10b5-1 plan trade. Holdings down 25% to 8,625 shares. | SEC filing Filed Aug 14, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Alan J Russell (Chief Scientific Officer and Director) sold 200,000 shares at $39.41 ($7.9M), marked as a 10b5-1 plan trade. Holdings down 89% to 24,555 shares. | SEC filing Filed Jul 2, 2026 |
| May 4–5, 2026 | Planned (10b5-1) | Joanne M. Donovan (CMO) sold 55,230 shares between May 4 and May 5 at about $37.88 ($2.1M), marked as a 10b5-1 plan trade. Holdings down 93% to 4,367 shares. | SEC filing Filed May 5, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Joanne M. Donovan (CMO) sold 28,662 shares at $32.31 ($926K), marked as a 10b5-1 plan trade. Holdings down 75% to 9,597 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 31, 2026 | Planned (10b5-1) | Joanne M. Donovan (CMO) sold 21,338 shares at $32.12 ($685K), marked as a 10b5-1 plan trade. Holdings down 69% to 9,597 shares. | SEC filing Filed Mar 31, 2026 |
| Mar 27, 2026 | Planned (10b5-1) | Joanne M. Donovan (CMO) sold 16,358 shares at $30.98 ($507K), marked as a 10b5-1 plan trade. Holdings down 63% to 9,597 shares. | SEC filing Filed Mar 30, 2026 |
| Jan 21, 2026 | Planned (10b5-1) | Badreddin Edris (Director) sold 115,471 shares at $29.44 ($3.4M), marked as a 10b5-1 plan trade. Holdings down 85% to 19,820 shares. | SEC filing Filed Jan 23, 2026 |
| Nov 11, 2025 | Purchase (code P) | Jonathan C Fox (Director) bought 10,700 shares at $18.64 ($199K), reported as a purchase (code P). Holdings up 82% to 23,702 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 13, 2025 |
31 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EWTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.